The Efficacy and Safety of Remimazolam Besylate Combined with Esketamine for Outpatient Colonoscopy: A Prospective, Randomized, Controlled Clinical Trial

被引:4
|
作者
Li, Wei [1 ]
Zhao, Jun [1 ]
Hao, Ruiping [1 ]
Wang, Shujuan [1 ]
Chen, Ming [1 ]
Liu, Huijun [1 ]
Qi, Le [1 ]
Hao, Zaijun [1 ,2 ]
机构
[1] Ordos Cent Hosp, Dept Anaesthesiol, Ordos, Inner Mongolia, Peoples R China
[2] Ordos Cent Hosp, Dept Anesthesiol, Ordos 017000, Inner Mongolia, Peoples R China
来源
关键词
remimazolam besylate; propofol; esketamine; colonoscopy; PROPOFOL SEDATION; ANESTHESIA; KETAMINE; DISORDERS; INDEX;
D O I
10.2147/DDDT.S425860
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Purpose: Evaluate the efficacy and safety of remimazolam besylate combined with esketamine for outpatient colonoscopy.Patients and methods: A total of 150 outpatients undergoing colonoscopy were randomized into two groups. A MOAA/S score <= 3 was maintained. The primary outcome was the rate of successful colonoscopy completion. Time indicators, hemodynamic parameters, the consumption of lidocaine, esketamine, propofol and remimazolam besylate, MOAA/S scores and bispectral index (BIS) values, the lowest SpO(2), body movement, the use of rescue medication, endoscopist and patient satisfaction, recall of the procedure, mini-mental state examination (MMSE), fatigue level and adverse events were recorded.Results: Procedure completion was equivalent between groups (P > 0.05). Both induction and awakening times were significantly shorter in the P group (P < 0.05). There were no significant differences in colonoscopy time and discharge time (P > 0.05). The lowest SpO(2) was significantly lower in the P group, while the level of fatigue was higher (P < 0.05). Patient satisfaction was significantly higher in the R group (P < 0.05). Endoscopist satisfaction was significantly higher in the P group (P < 0.05). There were no significant differences in both systolic and diastolic blood pressure between groups except at T5 and T6 (P > 0.05). Both HR and RR were significantly lower in the P group from T3 to T5 (P < 0.05). BIS values were significantly lower in the P group from T3 to T5, while MOAA/S was significantly lower in the P group at T3 and T4 (P < 0.05). Pain on injection was significantly higher in the P group (P < 0.05).Conclusion: Remimazolam besylate has a similar efficacy to propofol when combined with subanesthetic doses of esketamine during outpatient colonoscopy. Remimazolam besylate combined with esketamine resulted in less injection pain and more stable hemodynamics, although it prolonged induction and awakening time.
引用
收藏
页码:2875 / 2887
页数:13
相关论文
共 50 条
  • [21] Efficacy and safety of remimazolam tosilate versus propofol in patients undergoing day surgery: a prospective randomized controlled trial
    Luo, Wenchen
    Sun, Minli
    Wan, Jie
    Zhang, Zhenyu
    Huang, Jian
    Zhang, Jinlin
    Xiong, Wanxia
    Xia, Lirong
    Xu, Peiyao
    Miao, Changhong
    Zhang, Xuesong
    Liu, Mingyue
    Zhong, Jing
    BMC ANESTHESIOLOGY, 2023, 23 (01)
  • [22] Efficacy and safety of remimazolam tosilate versus propofol in patients undergoing day surgery: a prospective randomized controlled trial
    Wenchen Luo
    Minli Sun
    Jie Wan
    Zhenyu Zhang
    Jian Huang
    Jinlin Zhang
    Wanxia Xiong
    Lirong Xia
    Peiyao Xu
    Changhong Miao
    Xuesong Zhang
    Mingyue Liu
    Jing Zhong
    BMC Anesthesiology, 23
  • [23] Efficacy and safety of remimazolam besylate versus propofol during hysteroscopy: single-centre randomized controlled trial (vol 21, 156, 2021)
    Zhang, Xiaoqiang
    Li, Shuang
    Liu, Jing
    BMC ANESTHESIOLOGY, 2021, 21 (01)
  • [24] Safety and efficacy of etomidate/midazolam and propofol/midazolam sedations for screening colonoscopy: A prospective, randomized controlled trial
    Lee, Jung Min
    Choi, Seong Ji
    Jeon, Han Jo
    Jang, Sehyun
    Kim, Seung Han
    Lee, Jae Min
    Choi, Hyuk Soon
    Kim, Eun Sun
    Keum, Bora
    Jeen, Yoon Tae
    Chun, Hoon Jai
    Lee, Hong Sik
    Kim, Chang Duck
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 33 : 255 - 255
  • [25] Safety and efficacy of low-dose esketamine in laparoscopic cholecystectomy: a prospective, double-blind randomized controlled trial
    Zhao, Lu
    Li, Zhengyu
    Jin, Bi
    Hou, Nina
    Yang, Heng
    BMC ANESTHESIOLOGY, 2024, 24 (01)
  • [26] Comparison of remimazolam and propofol combined with low dose esketamine for pediatric same-day painless bidirectional endoscopy: a randomized, controlled clinical trial
    Chu, Tiantian
    Zhou, Siqi
    Wan, Yingfeng
    Liu, Qiuli
    Xin, Yueyang
    Tian, Zhang
    Yan, Tianqing
    Xu, Aijun
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [27] Safety and efficacy of low-dose esketamine in laparoscopic cholecystectomy: a prospective, double-blind randomized controlled trial
    Lu Zhao
    Zhengyu Li
    Bi Jin
    Nina Hou
    Heng Yang
    BMC Anesthesiology, 24
  • [28] Efficacy and Safety of a Subanesthetic Dose of Esketamine Combined with Propofol in Patients with Obesity Undergoing Painless Gastroscopy: A Prospective, Double-Blind, Randomized Controlled Trial
    Zheng, Longbin
    Wang, Yiteng
    Ma, Qing
    Liang, Wenbo
    Zhang, Xiaojing
    Ren, Zhiqiang
    Qin, Weimin
    Meng, Fan
    Li, Yuhong
    Fan, Guoxiang
    Yin, Ning
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2023, 17 : 1347 - 1356
  • [29] Efficacy and Safety of Remimazolam Besylate versus Dexmedetomidine for Sedation in Non-Intubated Older Patients with Agitated Delirium After Orthopedic Surgery: A Randomized Controlled Trial
    Deng, Yang
    Qin, Zhijun
    Wu, Qianyun
    Liu, Linsong
    Yang, Xi
    Ju, Xuan
    Zhang, Ying
    Liu, Lei
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2022, 16 : 2439 - 2451
  • [30] Efficacy and safety of esketamine for emergency endotracheal intubation in ICU patients: a double-blind, randomized controlled clinical trial
    Zhang, Xue
    Zhao, Xin
    Xu, Jiaxin
    Liu, Hong
    Yuan, Shiying
    Zhang, Jiancheng
    SCIENTIFIC REPORTS, 2025, 15 (01):